Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-23-048209

Options or other derivatives

  • Director acquired 11,297 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sturge Simon Director 2023-06-08 Grant or award · Option to Buy +11,297 11,297 D
Loading xslF345X04/ownership.xml…